Diabetes, Vol 48, Issue 3 588-594, Copyright © 1999 by American Diabetes Association

ARTICLES

Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr(db)/lepr(db) mice

JR Tonra, M Ono, X Liu, K Garcia, C Jackson, GD Yancopoulos, SJ Wiegand and V Wong
Regeneron Pharmaceuticals, Tarrytown, New York 10591, USA.

Systemic administration of brain-derived neurotrophic factor (BDNF) decreases nonfasted blood glucose in obese, non-insulin-dependent diabetic C57BLKS-Lepr(db)/lepr(db) (db/db) mice, with a concomitant decrease in body weight. By measuring percent HbA1c in BDNF-treated and pair-fed animals, we show that the effects of BDNF on nonfasted blood glucose levels are not caused by decreased food intake but reflect a significant improvement in blood glucose control. Furthermore, once established, this effect can persist for weeks after cessation of BDNF treatment. Oral glucose tolerance tests were performed to examine the effects of BDNF on blood glucose control in the fasted state and after an oral glucose challenge. BDNF treatment normalized fasting blood glucose from initially hyperglycemic levels and also showed evidence for beneficial, although less marked, effects on the ability to remove exogenous glucose from blood. One means to lower fasting blood glucose is to reduce the glucose output of peripheral tissues that normally play a part in the maintenance of fasting hyperglycemia. Because the liver is the major endogenous source of glucose in blood during fasting, and because hepatic weight and glucose output are increased in type 2 diabetes, we evaluated the effects of BDNF on liver tissue. BDNF reduced the hepatomegaly present in db/db mice, in association with reduced liver glycogen and reduced liver enzyme activity in serum, supporting the possible involvement of liver tissue in the mechanism of action for BDNF.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				H. Sha, J. Xu, J. Tang, J. Ding, J. Gong, X. Ge, D. Kong, and X. Gao Disruption of a novel regulatory locus results in decreased Bdnf expression, obesity, and type 2 diabetes in mice Physiol Genomics, October 19, 2007; 31(2): 252 - 263. [Abstract] [Full Text] [PDF]

				C. Wang, E. Bomberg, A. Levine, C. Billington, and C. M. Kotz Brain-derived neurotrophic factor in the ventromedial nucleus of the hypothalamus reduces energy intake Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1037 - R1045. [Abstract] [Full Text] [PDF]

				S. Vaynman and F. Gomez-Pinilla License to Run: Exercise Impacts Functional Plasticity in the Intact and Injured Central Nervous System by Using Neurotrophins Neurorehabil Neural Repair, December 1, 2005; 19(4): 283 - 295. [Abstract] [PDF]

				E. A. Fox and M. S. Byerly A mechanism underlying mature-onset obesity: evidence from the hyperphagic phenotype of brain-derived neurotrophic factor mutants Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2004; 286(6): R994 - R1004. [Abstract] [Full Text] [PDF]

				M. W. Sleeman, K. Garcia, R. Liu, J. D. Murray, L. Malinova, M. Moncrieffe, G. D. Yancopoulos, and S. J. Wiegand Ciliary neurotrophic factor improves diabetic parameters and hepatic steatosis and increases basal metabolic rate in db/db mice PNAS, November 25, 2003; 100(24): 14297 - 14302. [Abstract] [Full Text] [PDF]

				J. R. Goss, W. F. Goins, D. Lacomis, M. Mata, J. C. Glorioso, and D. J. Fink Herpes Simplex-Mediated Gene Transfer of Nerve Growth Factor Protects Against Peripheral Neuropathy in Streptozotocin-Induced Diabetes in the Mouse Diabetes, July 1, 2002; 51(7): 2227 - 2232. [Abstract] [Full Text] [PDF]

				M. Rios, G. Fan, C. Fekete, J. Kelly, B. Bates, R. Kuehn, R. M. Lechan, and R. Jaenisch Conditional Deletion Of Brain-Derived Neurotrophic Factor in the Postnatal Brain Leads to Obesity and Hyperactivity Mol. Endocrinol., October 1, 2001; 15(10): 1748 - 1757. [Abstract] [Full Text] [PDF]